TABLE 6.
Drugs and targets ranked by degree of the Drug-Target-Pathway network.
| Drugs/Targets | Degree |
|---|---|
| Lapatinib | 22 |
| Neratinib | 17 |
| Trastuzumab | 15 |
| Tucatinib | 13 |
| PIK3CA | 10 |
| MAPK8 | 10 |
| ERBB3 | 8 |
| CSF1R | 8 |
| EGFR | 7 |
| HSP90AA1 | 7 |
| ABCB1 | 7 |
| MCL1 | 6 |
| ERBB2 | 6 |
| ERBB4 | 6 |
| CYP3A4 | 4 |
| KRAS | 4 |
| MTOR | 4 |